tiprankstipranks
Trending News
More News >
Innate Pharma SA (IPHYF)
OTHER OTC:IPHYF

Compare Innate Pharma SA (IPHYF) vs. Competitors

Compare
27 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Innate Pharma SA
$2.16
$166.14M
-3.61
-25.69%
0 Buy
0 Hold
0 Sell
Hold
Genfit
$6.13
$308.48M
-7.26
68.87%
1 Buy
0 Hold
0 Sell
Moderate Buy
DBV Technologies
€2.99
€607.09M
-3.15
176.34%
1 Buy
0 Hold
0 Sell
Moderate Buy
Nanobiotix
€17.50
€859.34M
498.24%
1 Buy
0 Hold
0 Sell
Moderate Buy
OSE Immunotherapeutics SA
€5.12
€111.71M
-3.14
-26.48%
0 Buy
0 Hold
0 Sell
Moderate Buy
Sensorion SAS
€0.28
€97.99M
-2.88
-59.24%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IPHYF
Innate Pharma SA
2.16
-0.75
-25.69%
GNFTF
Genfit
6.13
2.51
69.10%
GB:0QAJ
DBV Technologies
2.99
2.12
243.68%
GB:0QAV
Nanobiotix
17.66
14.70
496.22%
DE:6OP
OSE Immunotherapeutics SA
4.97
-1.82
-26.80%
DE:RFM
Sensorion SAS
0.27
-0.37
-57.97%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts